Key result
Zinc pyrithione augments KCNQ1 current, but heteromultimeric KCNQ1-KCNE1 channels and native I(Ks) current are insensitive to it, indicating desensitization by the KCNE subunit.
The presence of the KCNE1 auxiliary subunit desensitizes the KCNQ1 channel to the chemical opener Zinc pyrithione, suggesting a mechanistic overlap in potentiation determinants.
May not affect native cardiac I(Ks); leaves open KCNE-specific drug design for KCNQ1.
Chemical openers for KCNQ potassium channels are useful probes both for understanding channel gating and for developing therapeutics. The five KCNQ isoforms (KCNQ1 to KCNQ5, or Kv7.1 to Kv7.5) are differentially localized. Therefore, the molecular specificity of chemical openers is an important subject of investigation. Native KCNQ1 normally exists in complex with auxiliary subunits known as KCNE. In cardiac myocytes, the KCNQ1-KCNE1 (IsK or minK) channel is thought to underlie the I(Ks) current, a component critical for membrane repolarization during cardiac action potential. Hence, the molecular and pharmacological differences between KCNQ1 and KCNQ1-KCNE1 channels have been important topics. Zinc pyrithione (ZnPy) is a newly identified KCNQ channel opener, which potently activates KCNQ2, KCNQ4, and KCNQ5. However, the ZnPy effects on cardiac KCNQ1 potassium channels remain largely unknown. Here we show that ZnPy effectively augments the KCNQ1 current, exhibiting an increase in current amplitude, reduction of inactivation, and slowing of both activation and deactivation. Some of these are reminiscent of effects by KCNE1. In addition, neither the heteromultimeric KCNQ1-KCNE1 channels nor native I(Ks) current displayed any sensitivity to ZnPy, indicating that the static occupancy by a KCNE subunit desensitizes the reversible effects by a chemical opener. Site-directed mutagenesis of KCNQ1 reveals that residues critical for the potentiation effects by either ZnPy or KCNE are clustered together in the S6 region overlapping with the critical gating determinants. Thus, the convergence of potentiation effects and molecular determinants critical for both an auxiliary subunit and a chemical opener argue for a mechanistic overlap in causing potentiation.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2008) studied this question. Zinc pyrithione (ZnPy) was evaluated on KCNQ1 current augmentation and sensitivity of KCNQ1-KCNE1 channels. Zinc pyrithione augments KCNQ1 current, but heteromultimeric KCNQ1-KCNE1 channels and native I(Ks) current are insensitive to it, indicating desensitization by the KCNE subunit.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: